Codexis (CDXS) Appoints Raymond De Vre to its Board

Go back to Codexis (CDXS) Appoints Raymond De Vre to its Board

Codexis Announces Appointment of Raymond De Vré, PhD, to Board of Directors

November 12, 2024 4:06 PM UTC

REDWOOD CITY, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the appointment of Raymond De Vré, PhD, to the Companys Board of Directors.

We are thrilled to have Raymond join the Codexis Board of Directors. He will be an invaluable resource to Codexis, said Stephen Dilly, MBBS, PhD, Chairman and Chief Executive Officer at Codexis. Raymond brings a deep understanding of the commercial and regulatory landscape as well as direct experience in oligonucleotide manufacturing.

... More